Brown R S, Jackson I M, Pohl S L, Reichlin S
Lancet. 1978 Apr 29;1(8070):904-6. doi: 10.1016/s0140-6736(78)90682-7.
The prevalence of serum thyroid-stimulating immunoglobulins (T.S.I.) in a variety of thyroid diseases was determined in 96 patients and 35 normal controls. Significantly elevated levels of T.S.I. were found not only in patients with Graves' disease and Hashimoto's thyroiditis but also in those with non-toxic and toxic multinodular goitre, whereas patients with a single autonomously functioning thyroid nodule, with subacute thyroiditis, and with "hyperthyroiditis" had levels which did not differ from those in the controls. We postulate that non-toxic multinodular goitre, like Graves' disease, may result from increased circulating T.S.I., which in some cases may be present in sufficient concentration to cause thyrotoxicosis.
对96例各种甲状腺疾病患者和35名正常对照者测定了血清促甲状腺素免疫球蛋白(T.S.I.)的患病率。不仅在格雷夫斯病和桥本甲状腺炎患者中发现T.S.I.水平显著升高,而且在非毒性和毒性多结节性甲状腺肿患者中也发现了显著升高,而单个自主性甲状腺结节、亚急性甲状腺炎和“甲状腺功能亢进性甲状腺炎”患者的T.S.I.水平与对照组无差异。我们推测,非毒性多结节性甲状腺肿可能与格雷夫斯病一样,是由循环中T.S.I.增加所致,在某些情况下,其浓度可能足以导致甲状腺毒症。